A foundation for the oral microbiome and metagenome - the major objective of this work is to provide curated genomic information, new bacterial isolates, and resources for scientists investigating the…
Active Grant Awarded
- Award ID
- R56DE016937
- Recipient
-
ADA Forsyth Institute, Inc. UEI MZ9DFVC2J1B7
- Awarding agency
-
National Institute of Dental and Craniofacial Research
National Institutes of Health, Department of Health and Human Services
- Obligated
- $476,883
Award facts
- Assistance listing
- 93.121 Oral Diseases and Disorders Research
- Completion date 17% complete
- Place of performance
- Cambridge, MA 02142, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, National Institute of Dental and Craniofacial Research awarded ADA Forsyth Institute, Inc. (doing business as The Forsyth Institute) $476,883 on September 17, 2026, under Grant R56DE016937, which is funded through the Oral Diseases and Disorders Research program (CFDA 93.121). The award is an assistance-type Grant, with the full amount obligated.
The project aims to strengthen oral microbiome research by expanding the Human Oral Microbiome Database (eHOMD), bringing previously uncultivable oral microbes into cultivation, and generating reference-quality genomic data for oral microbes. Aim 1 updates and refines eHOMD taxa with newly available genomic data, increases the scope of datasets represented, including global populations sampled in health and disease, and expands annotation and display of bacterial species pangenomes to illuminate the function of core and flexible genes.
The period of performance runs from September 17, 2026 through September 15, 2027. Place of performance is Cambridge, MA 02142, USA.
The program supports NIDCR extramural basic, translational, and clinical research in dental, oral, and craniofacial health and disease.
Description
A foundation for the oral microbiome and metagenome - the major objective of this work is to provide curated genomic information, new bacterial isolates, and resources for scientists investigating the role of oral microbes in human health and disease. Oral bacteria play roles not only in caries, periodontal disease, and cancer, but also in regulating healthy human physiology via nitrate metabolism. Oral bacteria can influence blood pressure and modulate risk for cardiovascular disease and diabetes. How the oral microbiome influences these conditions, however, is not well understood. Many oral bacteria cannot be grown in the lab, limiting the ability of scientists to analyze them experimentally. Phages (viruses that infect bacteria) and mobile genetic elements can carry antibiotic resistance genes and other important functions, but oral phages are only beginning to be explored. A major GAP in knowledge is lack of understanding of the roles of oral microbes in maintaining health and influencing oral and systemic disease. The goal of this project is to strengthen oral microbiome research by continued innovative expansion of the human oral microbiome database (EHOMD), together with bringing previously uncultivable oral microbes into cultivation and generating reference-quality genomic data for oral microbes. These resources will accelerate research progress by enabling synergy across studies, through curated synthesis of diverse and increasingly abundant sequence data, and by enabling new in vitro studies of previously uncultivable isolates. The goal of aim 1 of the project is to expand tools and data available in the EHOMD. Work on the project will update and refine EHOMD taxa with newly available genomic data; increase the scope of datasets represented in the EHOMD, including global populations sampled in health and disease; expand annotation and display of bacterial species pangenomes, to illuminate the function of core and flexible genes across species in the oral microbiome; and curate, characterize, and expand the foundational phage dataset and toolkit developed in an earlier cycle of the project. The goal of aim 2 is to allow in vitro investigation of as-yet-uncultivable oral taxa by obtaining isolates. Building on approaches that have previously been successful in bringing new taxa into cultivation, the project will focus on bacterial groups with high prevalence and abundance in the mouth, including bacteria associated with health as well as bacteria associated with disease. The goal of aim 3 is to obtain genome sequences for oral taxa currently lacking genomic information. Strategies for this work include generating reference-quality genome sequence, searching public databases for high-quality genomes sequenced by other investigators, and generating high-quality metagenome-assembled genomes for persistently uncultivable taxa using innovative long-read sequencing methods. Collectively, these aims will strengthen the genomic foundation for oral microbiome research with the goal of catalyzing reproducible, innovative studies on the role of oral microbes in health and disease and potentiating the development of robust bioengineering tools, probiotics, and therapeutics.
Quick answers
Who received award R56DE016937?
R56DE016937 was awarded to ADA Forsyth Institute, Inc. by National Institute of Dental and Craniofacial Research (National Institutes of Health) on September 17, 2026.
How much is award R56DE016937 worth?
$476,883 has been obligated on R56DE016937.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award